Sparstolonin B potentiates the antitumor activity of nanovesicle-loaded drugs by suppressing the phagocytosis of macrophages in vivo
Yuefeng Zhang, Zuo Mou, Wei Song, Xiaoqin He, Qin Yi, Zhekai Wang, Xietong Mao, Wei Wang, Yangtao Xu, Yang Shen, Peng Ma, Kaihuan Yu · 2024
Read Sparstolonin B potentiates the antitumor activity of nanovesicle-loaded drugs by suppressing the phagocytosis of macrophages in vivo by Yuefeng Zhang, Zuo Mou, Wei Song, Xiaoqin He, Qin Yi, Zhekai Wang, Xietong Mao, Wei Wang, Yangtao Xu, Yang Shen, Peng Ma, Kaihuan Yu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11657701.txt.
Description
Yuefeng Zhang and co-authors find, in a 2024 study, a way to keep drug-carrying nanovesicles alive longer in the bloodstream by briefly gagging the liver's cleanup crew. Vesicles borrowed from cells make fine delivery trucks, but macrophages in liver and spleen eat most of a dose within minutes. Tracing the eating to one receptor pathway, TLR2, the team tested a natural compound, sparstolonin B, that blocks it.
Pretreating mice forty minutes before injection cut the vesicles' capture, kept more of them circulating, and let more of their cargo, the chemotherapy doxorubicin, reach pancreatic tumors. Tumor growth slowed in consequence. Silencing the receptor's gene in dish experiments confirmed the mechanism. The authors present the pretreatment as a general escort strategy: a short, timed suppression of one appetite, traded for a longer working life for the medicine.
Catalog record
| CREATOR | Yuefeng Zhang, Zuo Mou, Wei Song, Xiaoqin He, Qin Yi, Zhekai Wang, Xietong Mao, Wei Wang, Yangtao Xu, Yang Shen, Peng Ma, Kaihuan Yu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |